9.07
price down icon9.66%   -0.97
after-market Dopo l'orario di chiusura: 9.00 -0.07 -0.77%
loading

Emergent Biosolutions Inc Borsa (EBS) Ultime notizie

pulisher
Oct 10, 2025

Short interest data insights for Emergent BioSolutions Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How strong is Emergent BioSolutions Inc. stock balance sheetJuly 2025 Update & Consistent Profit Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Emergent Biosolutions (NYSE:EBS) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Emergent BioSolutions Inc. (ER4) stock dividend growth reliableQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com

Oct 10, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) Shares Bounce 31% But Its Business Still Trails The Industry - simplywall.st

Oct 08, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - The Manila Times

Oct 08, 2025
pulisher
Oct 08, 2025

Emergent BioSolutions Inc. Announces Conference Call for Third Quarter 2025 Financial Results - Quiver Quantitative

Oct 08, 2025
pulisher
Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Stock Price Up 5.3%Still a Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Emergent Biosolutions (NYSE:EBS) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

Quantitative breakdown of Emergent BioSolutions Inc. recent moveTrade Ideas & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendationsWeekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Emergent BioSolutions Inc. (ER4) stock a buy during volatile marketsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 04:23:16 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Emergent BioSolutions Inc. stock a top pick in earnings season2025 Market Sentiment & Fast Moving Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Relative strength of Emergent BioSolutions Inc. in sector analysisWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to interpret RSI for Emergent BioSolutions Inc. stockPortfolio Update Report & Weekly Setup with ROI Potential - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Strategies to average down on Emergent BioSolutions Inc.Portfolio Value Report & AI Powered Market Trend Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Multi factor analysis applied to Emergent BioSolutions Inc.CEO Change & Entry Point Strategy Guides - newser.com

Oct 03, 2025
pulisher
Sep 28, 2025

Is Emergent BioSolutions Inc. stock poised for growth2025 Stock Rankings & Consistent Profit Alerts - newser.com

Sep 28, 2025
pulisher
Sep 28, 2025

Emergent BioSolutions Inc Stock Analysis and ForecastVolatility Index Analysis & Big Profit Small Budget - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Is Emergent BioSolutions Inc ER4 a good long term investmentMarket Insider Reports & Affordable Investment Strategies - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Emergent Biosolutions Inc. $EBS Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Emergent BioSolutions Inc.'s (NYSE:EBS) large institutional owners must be happy as stock continues to impress, up 10% over the past week - Yahoo Finance

Sep 26, 2025
pulisher
Sep 24, 2025

Emergent BioSolutions Inc. Reaffirms Commitment to Combat Opioid Crisis Through Awareness and Access to Naloxone Products - Quiver Quantitative

Sep 24, 2025
pulisher
Sep 24, 2025

45% of Retail Workers Have Witnessed Naloxone Use: Emergent BioSolutions Tackles Workplace Opioid Crisis - Stock Titan

Sep 24, 2025
pulisher
Sep 22, 2025

Emergent BioSolutions stock maintains Buy rating at H.C. Wainwright on $29M deal - Investing.com Canada

Sep 22, 2025
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Capitalizzazione:     |  Volume (24 ore):